The diagnostic test maker's panels could help to combat the spread of new coronavirus variants.
News & Analysis: T2 Biosystems
Investors are excited about the prospects of the company's COVID-19 diagnostic test.
The diagnostic innovator provided performance data for a product pipeline candidate aimed at diagnosing Lyme disease.
The diagnostic company is rebounding after a stock offering.